RxDoctor Payments Data

Gabrielle Clark, DPM

Foot & Ankle Surgery · New Orleans, LANPI 1134576754

Payments from drug & device makers

What this record shows

7 manufacturers reported payments, led by ALON Medical Technology at 38.1% of the total. Reporting peaked in 2020 at $614 and has fallen 96.7% since, to $20 in 2024. That places this record below the midpoint for foot & ankle surgery clinicians in LA, where the typical reported total is $2,260.

$1,157in general payments, 2019–2025

Across 29 payments — averaging $39.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ALON Medical Technology$441
  • Smith+Nephew$344
  • Arthrex$173
  • Organogenesis Inc.$147
  • Mimedx Group, Inc.$20
  • Alfasigma USA, Inc.$19
  • plus $13 from 1 others

What the payments were for

  • Travel & lodging$59852%
  • Food & beverage$55948%

General payments by program year

20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ALON Medical Technology1$441
Smith+Nephew19$344
Arthrex2$173
Organogenesis Inc.4$147
Mimedx Group, Inc.1$20
Alfasigma USA, Inc.1$19
Trice Medical, Inc.1$13

How this compares

$1,157 in reported general payments places this provider in the 35th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$2,663,911
Medicare patients
111
Services billed
2,492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole398$7,157
Ammonium Lactate74$1,193
Itraconazole11$366
Mupirocin25$187
Methylprednisolone16$134
Cephalexin11$50

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →